BCG January 8, 2025
Margot Bleys, Bilal Khan, John Wu, and Priya Chandran

Focusing on Innovation amid Complexity

Key Takeaways

The companies that thrive will focus on their core areas to drive innovation and efficiency while accelerating speed and agility.
  • Scientific understanding of the biological drivers of disease, combined with the ability to influence human biology, has never been greater. We expect new development to accelerate, delivering a wave of breakthrough drugs that will transform the treatment of diseases with significant unmet...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech, Trends
The next 15 drugs for Medicare price negotiations
Medicare Negotiations Could Fuel, Not Stifle, Innovation
Four Opportunities To Revitalize The US Biomedical Research Enterprise
Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says
Google DeepMind CEO: AI-Designed Drugs Coming to Clinical Trials in 2025

Share This Article